Answers are grounded in this paper and cite their sources.
/L. The ETB tapering was performed by decreasing the dose by 25 mg every 2 weeks to a minimum dose of 25 mg every other day for all patients. Right upper panel: Clinical outcomes in patients treated with first-line ETB + DEX. Patients displayed a qualitatively longer response duration and qualitatively reduced usage of rescue medication. Right lower panel: The immunological T-cell response was different in treatment responders and non-responders. Patients with sustained response (responders) displayed a high T-cell clonality at baseline. Clones are depicted as bubbles (right side).
No takes yet. Share an insight, caveat, or question.
Schmidt‐Barbo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: